Half-year report · HY
7446.TEDINET S100Y3KO
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥18.9bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥34.4bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.8bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥530m | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥325m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥565m | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥595m | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥355m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥576m | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥400m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥396m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥429m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥269m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥400m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥273m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥20.4bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥18.4bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥18.5bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.8bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥10.4bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥8.5bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.7bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.7bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥925m | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.7bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥911m | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥745m | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.9bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥150m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥674m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥33m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥19m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥62m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥53m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥439.52 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥475.93 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥298.4 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 41.5% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.0% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| Academia Life Science Sales Groupreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥1.3bn |
| Academia Life Science Sales Groupreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥1.3bn |
| Industry Sales Groupreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥9.6bn |
| Industry Sales Groupreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥9.6bn |
| Medical Sales Groupreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥8.0bn |
| Medical Sales Groupreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥8.0bn |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥18.9bn |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥18.9bn |
| Academia Life Science Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥1.5bn |
| Academia Life Science Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥1.5bn |
| Industry Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥9.1bn |
| Industry Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥9.1bn |
| Medical Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥7.2bn |
| Medical Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥7.2bn |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥17.8bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥17.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 510
| Item | Context | Value | Unit |
|---|---|---|---|
| Selling general and administrative expenses | Prior1InterimDuration | 1354357000 | JPY |
| Selling general and administrative expenses | InterimDuration | 1328585000 | JPY |
| Operating income | Prior1InterimDuration | 325036000 | JPY |
| Operating income | InterimDuration | 530467000 | JPY |
| Interest income noi | Prior1InterimDuration | 2403000 | JPY |
| Interest income noi | InterimDuration | 3322000 | JPY |
| Dividends income noi | Prior1InterimDuration | 24212000 | JPY |
| Dividends income noi | InterimDuration | 28386000 | JPY |
| Commission fee noi | Prior1InterimDuration | 5062000 | JPY |
| Commission fee noi | InterimDuration | 4405000 | JPY |
| Miscellaneous income noi | Prior1InterimDuration | 4233000 | JPY |
| Miscellaneous income noi | InterimDuration | 3647000 | JPY |
| Other noi | Prior1InterimDuration | 128000 | JPY |
| Other noi | InterimDuration | 173000 | JPY |
| Non operating income | Prior1InterimDuration | 36039000 | JPY |
| Non operating income | InterimDuration | 39934000 | JPY |
| Interest expenses noe | Prior1InterimDuration | 2002000 | JPY |
| Interest expenses noe | InterimDuration | 2639000 | JPY |
| Commission fee noe | Prior1InterimDuration | 2858000 | JPY |
| Commission fee noe | InterimDuration | 437000 | JPY |
| Miscellaneous loss noe | Prior1InterimDuration | 667000 | JPY |
| Miscellaneous loss noe | InterimDuration | 143000 | JPY |
| Loss on investments in partnership noe | Prior1InterimDuration | 580000 | JPY |
| Loss on investments in partnership noe | InterimDuration | 2657000 | JPY |
| Non operating expenses | Prior1InterimDuration | 6109000 | JPY |
| Non operating expenses | InterimDuration | 5877000 | JPY |
| Ordinary income | Prior1InterimDuration | 354966000 | JPY |
| Ordinary income | InterimDuration | 564524000 | JPY |
| Gain on sales of investment securities ei | Prior1InterimDuration | － | JPY |
| Gain on sales of investment securities ei | InterimDuration | 12545000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1InterimDuration | 45506000 | JPY |
| Gain on sales of noncurrent assets ei | InterimDuration | － | JPY |
| Extraordinary income | Prior1InterimDuration | 45506000 | JPY |
| Extraordinary income | InterimDuration | 12545000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1InterimDuration | 148000 | JPY |
| Loss on retirement of noncurrent assets el | InterimDuration | 600000 | JPY |
| Extraordinary loss | Prior1InterimDuration | 148000 | JPY |
| Extraordinary loss | InterimDuration | 600000 | JPY |
| Income before income taxes | Prior1InterimDuration | 400325000 | JPY |
| Income before income taxes | InterimDuration | 576469000 | JPY |
| Income taxes current | Prior1InterimDuration | 117374000 | JPY |
| Income taxes current | InterimDuration | 135031000 | JPY |
| Income taxes deferred | Prior1InterimDuration | 10369000 | JPY |
| Income taxes deferred | InterimDuration | 41611000 | JPY |
| Income taxes | Prior1InterimDuration | 127744000 | JPY |
| Income taxes | InterimDuration | 176643000 | JPY |
| Profit loss | Prior1InterimDuration | 272580000 | JPY |
| Profit loss | InterimDuration | 399825000 | JPY |
| Profit loss attributable to non controlling interests | Prior1InterimDuration | 3728000 | JPY |
| Profit loss attributable to non controlling interests | InterimDuration | 3845000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |